Biomea Fusion to Participate in Upcoming Investor Conferences
Globe Newswire•12/11/2026•16:01 ET
1
Key Highlights
- ➤Biomea will present at Jefferies Global Healthcare Conference on November 19, 2026
- ➤Biomea will hold investor meetings at Citi’s 2026 Global Healthcare Conference December 2
- ➤Biomea will present at Piper Sandler’s 38th Annual Healthcare Conference December 3
- ➤Management will discuss oral small molecule therapies icovamenib and BMF-650
SAN CARLOS, Calif., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage biopharmaceutical company, today announced that members of its management team will participate in the following upcoming investor conferences: * Jefferies Global Healthcare Conference in London: Biomea will participate in a fireside chat discussion on November 19, 2026, at 8:30 EST, 1:30 p.m. GMT in London, England. Management will also participate in one-on-one investor meetings during the conference.
* Citi's 2026 Global Healthcare Conference: Management will participate in one-on-one investor meetings on December 2, 2026, in Miami, Florida.
Get started
Create a free account to read the full story.